Scientific Programme (General) 2008

Please note that the programme below may be subjected to changes (updated version 13th November).

Sunday, November 16th

10.00-15.00

Meetings for other organisations

 

15.00-17.00

Update Committees meetings

 

16.00-18.00

Registration desk

 

18.00-20.00

Reception

 

20.00-22.00

Chairperson's and Speaker's dinner

 

 

 

 

Monday, November 17th

 

07.00-16.30

Registration desk

 

08.30-08.45

Welcome address and introduction
Nils Wahlgren, Stockholm, and Bo Norrving, Lund

 

08.45-10.10

Session: Carotid endarterectomy vs angioplasty
Chairs: Philip Bath, Nottingham and Jean-Louis Mas, Paris /Secretary: Konstantinos Kostulas, Stockholm

 

08.45-09.05

The SPACE study: Long-term results of the Stent-protected percutaneous angioplasty of the carotid vs endarterectomy study
Michael Hennerici, Mannheim

 
09.05-09.25 The EVA-3S-study: Long-term results ofthe Endarterectomy vs angioplasty in patients with symptomatic severe carotid stenosis study
Jean-Louis Mas, Paris
 

09.25-09.45

The Cavatas study: Long-term results of the Carotid and vertebral artery transluminal angioplasty study
Martin Brown, London

 

09.45-09.55

Presentation of draft statement
Konstantinos Kostulas

 

09.55-10.10

Consensus discussion and statement
Chaired Philip Bath, Nottingham
Additional discussants: Ulf Hedin. Stockholm, and Michael Söderman, Stockholm

 

10.10-10.40

Special lecture: Reflections upon the Carotid Artery
Chair: Nils Wahlgren
Speaker: Henry JM Barnett, London Ontario

 

10.40-11.10 Coffee Break  

11.10-12.30

Session: Antithrombotic therapy
Chair: Didier Leys, Lille, and Anna Czlonkowska, Warsaw /Secretary: Mia von Euler, Stockholm

 

11.10-11.30

After PROFESS: Benefit/risk of antiplatelet treatments, updated review
Hans-Christoph Diener, Essen

 
11.30-11.45 After PROFESS: First choice antiplatelet therapy is combined dipyridamole and aspirin
Ale Algra, Utrecht (please note that this is an invited position talk which does not necessarily reflect the speakers personal view)
 

11.45-12.00

After PROFESS: First choice antiplatelet therapy is clopidogrel
Pierre Amarenco, Paris (please note that this is an invited position talk which does not necessarily reflect the speakers personal view)

 

12.00-12.10

Presentation of draft statement
Mia von Euler, Stockholm

 

12.10-12.30

Consensus discussion and statement
Chaired by Didier Leys, Lille

 

12.30-13.30

Lunch and poster exhibition

 

13.30-14.35

Session: TIA - still a clinical definition?
Chair: Peter Ringleb, Heidelberg and Ljiljana Bumbasirevic, Belgrade /Secretary: Ruben Tamazyan, Paris

 

13.30-13.50 TIA is a clinical definition
Bo Norrving, Lund
 

13.50-14.10

TIA is a tissue-based definition
Peter Kelly, Dublin

 

14.10-14.20

Presentation of draft statement
Ruben Tamazyan, Paris

 

14.20-14.35

Consensus discussion and statement
Chaired by Peter Ringleb

 

14.35-15.05

Coffee break

 

15.05-16.15

Session: TIA - management in TIA clinics or Stroke Unit care?
Chair: Peter Ringleb, Heidelberg and Vida Demarin, Zagreb/Secretary: Jean-Luc af Geijerstam, Stockholm

 

15.05-15.25 TIA is an emergency - use an emergency TIA clinic
Pierre Amarenco, Paris
 
15.25-15.45 TIA is an emergency - admit to an acute stroke unit
Gary Ford, Newcastle
 
15.45-15.55 Presentation of draft statement
Jean-Luc af Geijerstam, Stockholm
 

15.55-16.15

Consensus discussion and statement
Chaired by Peter Ringleb

 

16.15-16.25

Summary and closing of the first day of the meeting, original programme
Nils Wahlgren, Stockholm

 

16.25-17.00

Karolinska Stroke Award Ceremony
Ceremony in the presence of the President of Karolinska Institutet Harriet Wallberg-Henriksson

 
  All participants are welcome to the following satellite session:  

17.05-18.05

SITS investigators' open session
Open for all meeting participants

 
17.05-17.20 SITS - an update on ongoing and planned activities
Nils Wahlgren, Stockholm
 
17.20-17.30 HASTA (Hyperacute Stroke Alarm) Study in Stockholm County
Leif Svensson, Stockholm
 
17.30-17.45

International Stroke Trial
Veronica Murray. Stockholm

 
17.45-17.55 Citicholine in acute stroke - a study concept for SITS
Vladimir Hachinski, London, Ontario
 
17.55-18.10 Randomised controlled trial on mechanical retraction of thrombus in acute stroke using the MERCI device
Tommy Andersson, Stockholm
 

19.30

Gala Dinner

 

 

 

 

Tuesday, November 18th

 

08.30-08.35

Introduction to day 2

 

08.35-10.25

Session: Should the time window for intravenous thrombolysis be extended?
Chair: Markku Kaste, Helsinki, and Robert Mikulik, Brno /Secretary: Nikolaos Kostulas, Stockholm

 

08.35-08.55

ECASS 3 - main results
Kennedy R Lees, Glasgow

 

08.55-09.10 Outcomes for patients treated between 3 and 4.5 hours in the SITS register
Nils Wahlgren, Stockholm
 
09.10-09.25 Updated pooled analysis of randomised trials of intravenous alteplase in acute ischaemic stroke
Danilo Toni, Rome
 

09.25-09.40

Updated Cochrane review of intravenous thrombolysis for acute ischaemic stroke
Peter Sandercock, Edinburgh

 

09.40-09.50

Extend the time window - yes
Antoni Davalos, Badalona (please note that this is an invited position talk which does not necessarily reflect the speakers personal view)

 

09.50-10.00 Extend the time window - no
Peter Sandercock, Edinburgh (please note that this is an invited position talk which does not necessarily reflect the speakers personal view)
 
10.00-10.10 Presentation of draft statement
Nikolaos Kostulas, Stockholm
 

10.10-10.25

Consensus discussion and statement
Chaired by Markku Kaste, Helsinki

 

10.25-10.55

Coffee break

 

10.55-11.25

Special lecture: Is the mismatch concept valid?
Chair: Bo Norrving, Lund
Speaker: Jan Sobesky, Cologne

 

11.25-12.30

Session: Management of hyperglycemia and diabetes mellitus in stroke
Chair: Keith Muir, Glasgow/ Secretary: Christina Sjöstrand, Stockholm
 
11.25-11.45 Update on treatment of diabetes mellitus after stroke in the perspective of the ACCORD and ADVANCE studies
Per Wester, Umeå
 
11.45-12.05 Update on management of hyperglycemia in the acute phase of stroke
Natan Bornstein, Tel Aviv
 
12.05-12.15 Presentation of draft statement
Christina Sjöstrand, Stockholm
 
12.15-12.30

Consensus discussion and statement
Chaired by Keith Muir, Glasgow

 

12.30-13.25

Lunch and poster exhibition

 

13.25-13.45

Special lecture: Is vascular cognitive impairment a useful concept?
Chair: Nils Wahlgren, Stockholm
Speaker: Vladimir Hachinski, London, Ontario

 

13.45-14.45

Session: Blood pressure management in the acute phase of stroke
Chair: Jacques De Keyser, Brussels and László Csiba, Debrecen/ Secretary: Magnus Thorén, Stockholm

 

13.45-14.05

Treatment with telmisartan, a blood pressure lowering agent, within the first 3 days of acute ischaemic stroke. Results from PROFESS
Philip Bath, Nottingham

 

14.05-14.20 Relation of blood pressure with symptomatic intracerebral haemorrhage, mortality and independence at three months, based on data from 10,581 patients in SITS
Niaz Ahmed, Stockholm
 
14.20-14.30 Presentation of draft statement
Magnus Thorén, Stockholm
 

14.30-14.45

Consensus discussion and statement
Jacques De Keyser, Brussels

 

14.45-15.15

Coffee break

 

15.15-17.00

Session: Management of intracranial aneurysms and subarachnoid haemorrhage
Chair Thorsten Steiner, Heidelberg, Co-Chair Mikael Svensson, Stockholm /Secretaries: Tommy Andersson. Stockholm and Staffan Holmin, Stockholm

 

15.15-15.35

Surgical treatment
Andreas Unterberg, Heidelberg

 

15.35-15.55 Neuroradiological diagnosis and intravascular management
René Chapot, Essen
 

15.55-16.15

Medical management
Gabriel Rinkel, Utrecht

 

16.15-16.35 Epidemilogical aspects
Seppo Juvela, Helsinki
 
16.35-16.45 Presentation of draft consensus statement
Tommy Andersson, Stockholm
 
16.45-17.00

Consensus discussion and statement
Chaired by Thorsten Steiner, Heidelberg

 

17.00-17.15

Summary and closing of the meeting
Nils Wahlgren, Stockholm, and Bo Norrving. Lund

 

 

Karolinska Stroke Update